Aerovate Therapeutics Inc AVTE:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
16.58quote price arrow up+0.86 (+5.47%)
Volume
50,403
52 week range
7.74 - 27.83
Loading...
  • Open15.46
  • Day High18.20
  • Day Low15.06
  • Prev Close15.72
  • 52 Week High27.83
  • 52 Week High Date08/04/22
  • 52 Week Low7.74
  • 52 Week Low Date01/21/22

Key Stats

  • Market Cap405.38M
  • Shares Out24.45M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change40.63

KEY STATS

  • Open15.46
  • Day High18.20
  • Day Low15.06
  • Prev Close15.72
  • 52 Week High27.83
  • 52 Week High Date08/04/22
  • 52 Week Low7.74
  • 52 Week Low Date01/21/22
  • Market Cap405.38M
  • Shares Out24.45M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change40.63

RATIOS/PROFITABILITY

  • EPS (TTM)-1.56
  • P/E (TTM)-10.61
  • Fwd P/E (NTM)-8.25
  • EBITDA (TTM)-37.663M
  • ROE (TTM)-57.66%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aerovate Therapeutics Inc

 

Profile

MORE
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The Company's lead program is a drug that addresses the core disease processes of pulmonary arterial hypertension (PAH). AV-101 is an inhaled dry powder formulation of imatinib that conveniently delivers the medicine directly to the diseased lung tissues while reducing systemic adverse...
Mark Iwicki
Independent Chairman of the Board
Timothy Noyes
Chief Executive Officer, Director
Benjamin Dake Ph.D.
President, Chief Operating Officer, Secretary
George Eldridge
Chief Financial Officer, Treasurer
Address
930 Winter Street, Suite M-500
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
HUMA
Humacyte Inc
3.26-0.10-2.98%
PHAT
Phathom Pharmaceuticals Inc
11.08+0.50+4.73%
AUTL
Autolus Therapeutics PLC
2.14-0.09-4.04%
LXRX
Lexicon Pharmaceuticals Inc
2.40-0.01-0.41%
TCRT
Alaunos Therapeutics Inc
1.72-0.26-13.13%